Vaccines against COVID-19

被引：25

作者：

Locht, Camille ^{[1
]}

机构：

[1] Univ Lille, Inst Pasteur Lille, Ctr Infect & Immun Lille, CNRS,Inserm,CHU Lille,U1019,UMR9017, F-59000 Lille, France

来源：

ANAESTHESIA CRITICAL CARE & PAIN MEDICINE | 2020年 / 39卷 / 06期

关键词：

Adenovirus; mRNA vaccine; Neutralising antibodies;

D O I：

10.1016/j.accpm.2020.10.006

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

引用

页码：703 / 705

页数：3

共 20 条

[1] Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults [J].

Anderson, E. J. ;

Rouphael, N. G. ;

Widge, A. T. ;

Jackson, L. A. ;

Roberts, P. C. ;

Makhene, M. ;

Chappell, J. D. ;

Denison, M. R. ;

Stevens, L. J. ;

Pruijssers, A. J. ;

McDermott, A. B. ;

Flach, B. ;

Lin, B. C. ;

Doria-Rose, N. A. ;

O'Dell, S. ;

Schmidt, S. D. ;

Corbett, K. S. ;

Swanson, P. A., II ;

Padilla, M. ;

Neuzil, K. M. ;

Bennett, H. ;

Leav, B. ;

Makowski, M. ;

Albert, J. ;

Cross, K. ;

Edara, V. V. ;

Floyd, K. ;

Suthar, M. S. ;

Martinez, D. R. ;

Baric, R. ;

Buchanan, W. ;

Luke, C. J. ;

Phadke, V. K. ;

Rostad, C. A. ;

Ledgerwood, J. E. ;

Graham, B. S. ;

Beigel, J. H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (25) :2427-2438

[2] PROTECTIVE AND DISEASE-ENHANCING IMMUNE-RESPONSES TO RESPIRATORY SYNCYTIAL VIRUS [J].

ANDERSON, LJ ;

HEILMAN, CA .

JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (01) :1-7

[3] A perspective on potential antibody-dependent enhancement of SARS-CoV-2 [J].

Arvin, Ann M. ;

Fink, Katja ;

Schmid, Michael A. ;

Cathcart, Andrea ;

Spreafico, Roberto ;

Havenar-Daughton, Colin ;

Lanzavecchia, Antonio ;

Corti, Davide ;

Virgin, Herbert W. .

NATURE, 2020, 584 (7821) :353-363

[4] A Bold Response to the COVID-19 Pandemic Medical Students, National Service, and Public Health [J].

Bauchner, Howard ;

Sharfstein, Joshua .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (18) :1790-1791

[5] Russian SARS-CoV-2 vaccine [J].

Caddy, Sarah .

BMJ-BRITISH MEDICAL JOURNAL, 2020, 370

[6] Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial [J].

Folegatti, Pedro M. ;

Ewer, Katie J. ;

Aley, Parvinder K. ;

Angus, Brian ;

Becker, Stephan ;

Belij-Rammerstorfer, Sandra ;

Bellamy, Duncan ;

Bibi, Sagida ;

Bittaye, Mustapha ;

Clutterbuck, Elizabeth A. ;

Dold, Christina ;

Faust, Saul N. ;

Finn, Adam ;

Flaxman, Amy L. ;

Hallis, Bassam ;

Heath, Paul ;

Jenkin, Daniel ;

Lazarus, Rajeka ;

Makinson, Rebecca ;

Minassian, Angela M. ;

Pollock, Katrina M. ;

Ramasamy, Maheshi ;

Robinson, Hannah ;

Snape, Matthew ;

Tarrant, Richard ;

Voysey, Merryn ;

Green, Catherine ;

Douglas, Alexander D. ;

Hill, Adrian V. S. ;

Lambe, Teresa ;

Gilbert, Sarah C. ;

Pollard, Andrew J. .

LANCET, 2020, 396 (10249) :467-478

[7] An mRNA Vaccine against SARS-CoV-2-Preliminary Report [J].

Jackson, L. A. ;

Anderson, E. J. ;

Rouphael, N. G. ;

Roberts, P. C. ;

Makhene, M. ;

Coler, R. N. ;

McCullough, M. P. ;

Chappell, J. D. ;

Denison, M. R. ;

Stevens, L. J. ;

Pruijssers, A. J. ;

McDermott, A. ;

Flach, B. ;

Doria-Rose, N. A. ;

Corbett, K. S. ;

Morabito, K. M. ;

O'Dell, S. ;

Schmidt, S. D. ;

Swanson, P. A. ;

Padilla, M. ;

Mascola, J. R. ;

Neuzil, K. M. ;

Bennett, H. ;

Sun, W. ;

Peters, E. ;

Makowski, M. ;

Albert, J. ;

Cross, K. ;

Buchanan, W. ;

Pikaart-Tautges, R. ;

Ledgerwood, J. E. ;

Graham, B. S. ;

Beigel, J. H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (20) :1920-1931

[8] Dengue vaccine-induced CD8+ T cell immunity confers protection in the context of enhancing, interfering maternal antibodies [J].

Lam, Jian Hang ;

Chua, Yen Leong ;

Lee, Pei Xuan ;

Gomez, Julia Maria Martinez ;

Ooi, Eng Eong ;

Alonso, Sylvie .

JCI INSIGHT, 2017, 2 (24)

[9] Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections [J].

Libraty, DH ;

Endy, TP ;

Houng, HSH ;

Green, S ;

Kalayanarooj, S ;

Suntayakorn, S ;

Chansiriwongs, W ;

Vaughn, DW ;

Nisalak, A ;

Ennis, FA ;

Rothman, AL .

JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (09) :1213-1221

[10] Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia [J].

Logunov, Denis Y. ;

Dolzhikova, Inna V. ;

Zubkova, Olga V. ;

Tukhvatullin, Amir I. ;

Shcheblyakov, Dmitry V. ;

Dzharullaeva, Alina S. ;

Grousova, Daria M. ;

Erokhova, Alina S. ;

Kovyrshina, Anna V. ;

Botikov, Andrei G. ;

Izhaeva, Fatima M. ;

Popova, Olga ;

Ozharovskaya, Tatiana A. ;

Esmagambetov, Ilias B. ;

Favorskaya, Irina A. ;

Zrelkin, Denis I. ;

Voronina, Daria V. ;

Shcherbinin, Dmitry N. ;

Semikhin, Alexander S. ;

Simakova, Yana V. ;

Tokarskaya, Elizaveta A. ;

Lubenets, Nadezhda L. ;

Egorova, Daria A. ;

Shmarov, Maksim M. ;

Nikitenko, Natalia A. ;

Morozova, Lola F. ;

Smolyarchuk, Elena A. ;

Kryukov, Evgeny V. ;

Babira, Vladimir F. ;

Borisevich, Sergei V. ;

Naroditsky, Boris S. ;

Gintsburg, Alexander L. .

LANCET, 2020, 396 (10255) :887-897

← 1 2 →